This story has been updated to include comments from advisory firm Glass Lewis.

NEW YORK (GenomeWeb) – Investment firm Lone Star Value Management has issued an open letter to all Enzo Biochem shareholders, urging them to vote for two Lone Star nominees to Enzo's board of directors.

In the letter published Tuesday, Lone Star said it has "serious concerns" with Enzo's "poor performance and disregard for shareholder rights."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.